BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 8225749)

  • 1. The design and analysis of cholera vaccine trials: recent lessons from Bangladesh.
    Clemens J; Sack D; Rao M; Chakraborty J; Kay B; Ahmed F; Khan MR; van Loon FP; Svennerholm AM; Holmgren J
    Int J Epidemiol; 1993 Aug; 22(4):724-30. PubMed ID: 8225749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
    Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
    Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field trial of oral cholera vaccines in Bangladesh.
    Clemens JD; Sack DA; Harris JR; Chakraborty J; Khan MR; Stanton BF; Kay BA; Khan MU; Yunus M; Atkinson W
    Lancet; 1986 Jul; 2(8499):124-7. PubMed ID: 2873397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.
    Durham LK; Longini IM; Halloran ME; Clemens JD; Nizam A; Rao M
    Am J Epidemiol; 1998 May; 147(10):948-59. PubMed ID: 9596473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera in Africa: lessons on transmission and control for Latin America.
    Glass RI; Claeson M; Blake PA; Waldman RJ; Pierce NF
    Lancet; 1991 Sep; 338(8770):791-5. PubMed ID: 1681168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vaccines against cholera: lessons from Vietnam and elsewhere.
    Levine MM
    Lancet; 1997 Jan; 349(9047):220-1. PubMed ID: 9014902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines.
    Clemens JD; van Loon FF; Rao M; Sack DA; Ahmed F; Chakraborty J; Khan MR; Yunus M; Harris JR; Svennerholm AM
    Am J Epidemiol; 1992 Apr; 135(8):865-74. PubMed ID: 1585899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of classic cholera in Bangladesh.
    Siddique AK; Baqui AH; Eusof A; Haider K; Hossain MA; Bashir I; Zaman K
    Lancet; 1991 May; 337(8750):1125-7. PubMed ID: 1674016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits.
    Sanchez JL; Vasquez B; Begue RE; Meza R; Castellares G; Cabezas C; Watts DM; Svennerholm AM; Sadoff JC; Taylor DN
    Lancet; 1994 Nov; 344(8932):1273-6. PubMed ID: 7967990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccines for cholera control.
    Chaturvedi S; Chaturvedi S
    Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.
    Clemens JD; Sack DA; Harris JR; Van Loon F; Chakraborty J; Ahmed F; Rao MR; Khan MR; Yunus M; Huda N
    Lancet; 1990 Feb; 335(8684):270-3. PubMed ID: 1967730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
    Im J; Islam MT; Ahmmed F; Kim DR; Chon Y; Zaman K; Khan AI; Ali M; Marks F; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007179. PubMed ID: 30870416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area.
    Clemens JD; Sack DA; Rao MR; Chakraborty J; Khan MR; Kay B; Ahmed F; Banik AK; van Loon FP; Yunus M
    J Infect Dis; 1992 Nov; 166(5):1029-34. PubMed ID: 1402014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.
    Chowdhury MI; Sheikh A; Qadri F
    Expert Rev Vaccines; 2009 Dec; 8(12):1643-52. PubMed ID: 19943759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera cases cluster in time and space in Matlab, Bangladesh: implications for targeted preventive interventions.
    Debes AK; Ali M; Azman AS; Yunus M; Sack DA
    Int J Epidemiol; 2016 Dec; 45(6):2134-2139. PubMed ID: 27789673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
    Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD
    Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.
    Islam MT; Chowdhury F; Qadri F; Sur D; Ganguly NK
    Vaccine; 2020 Feb; 38 Suppl 1():A127-A131. PubMed ID: 31301917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial.
    Ali M; Qadri F; Kim DR; Islam MT; Im J; Ahmmed F; Khan AI; Zaman K; Marks F; Kim JH; Clemens JD
    Lancet Infect Dis; 2021 Oct; 21(10):1407-1414. PubMed ID: 34146473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.